Dora Il'yasova is a seasoned epidemiologist with over 20 years of experience working in both academic and clinical research settings. She has extensive expertise in biomarker-based epidemiology, with a focus on biomarkers of oxidative stress, subclinical inflammation, apoptosis, fatty acid metabolism, and exposure to toxic and essential metals and neurocarcinogens. She is skilled in using a cell-based approach to conduct epidemiological studies and examining cellular functional responses to different stimuli. Il'yasova's research has led to paradigm-shifting work, with discoveries shedding light on individual resilience to drug-induced toxicities, response to radiation, and environmental pollutants. She has published 49 leading author publications and co-authored an additional 44 publications.

Il'yasova holds a PhD in Epidemiology from the University of North Carolina at Chapel Hill, a Doctoral Program in Nutrition from the University of North Carolina at Greensboro, and a Doctoral Program in Biochemistry from the AN Bach Institute of Biochemistry in Moscow. She also completed a Research Internship at the AN Bach Institute of Biochemistry and a Master of Science in Biochemistry at Moscow State University.

Il'yasova has held various positions throughout her career, including as an associate consultant professor at Duke University Health System, senior epidemiologist at CREATIVE SCIENTIST, INC., and associate professor at Georgia State University. She has also been a project manager at the University of North Carolina at Chapel Hill, and a laboratory technician at Bowman Gray School of Medicine's Department of Biochemistry and Experimental Therapeutics Laboratory.

Some notable accomplishments on Il'yasova's record include pioneering the development of a model based on circulating progenitor cells, leading population-based case-control studies on rectal cancer and inflammatory breast cancer, and spearheading groundbreaking collaborations in the study of rare cancers.